204 related articles for article (PubMed ID: 26936507)
1. A dominant gain-of-function mutation in universal tyrosine kinase SRC causes thrombocytopenia, myelofibrosis, bleeding, and bone pathologies.
Turro E; Greene D; Wijgaerts A; Thys C; Lentaigne C; Bariana TK; Westbury SK; Kelly AM; Selleslag D; Stephens JC; Papadia S; Simeoni I; Penkett CJ; Ashford S; Attwood A; Austin S; Bakchoul T; Collins P; Deevi SV; Favier R; Kostadima M; Lambert MP; Mathias M; Millar CM; Peerlinck K; Perry DJ; Schulman S; Whitehorn D; Wittevrongel C; ; De Maeyer M; Rendon A; Gomez K; Erber WN; Mumford AD; Nurden P; Stirrups K; Bradley JR; Raymond FL; Laffan MA; Van Geet C; Richardson S; Freson K; Ouwehand WH
Sci Transl Med; 2016 Mar; 8(328):328ra30. PubMed ID: 26936507
[TBL] [Abstract][Full Text] [Related]
2. De novo variant in tyrosine kinase SRC causes thrombocytopenia: case report of a second family.
De Kock L; Thys C; Downes K; Duarte D; Megy K; Van Geet C; Freson K
Platelets; 2019; 30(7):931-934. PubMed ID: 31204551
[TBL] [Abstract][Full Text] [Related]
3. Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease.
Palma-Barqueros V; Revilla N; Zaninetti C; Galera AM; Sánchez-Fuentes A; Zámora-Cánovas A; Bohdan N; Padilla J; Marín-Quilez A; Rodriguez-Alen A; Fuster JL; Greinacher A; Vicente V; Bastida JM; Rivera J; Lozano ML
Blood Adv; 2022 Sep; 6(17):5244-5255. PubMed ID: 35349645
[TBL] [Abstract][Full Text] [Related]
4. The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes.
De Kock L; Freson K
Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33255186
[TBL] [Abstract][Full Text] [Related]
5. Congenital macrothrombocytopenia with focal myelofibrosis due to mutations in human G6b-B is rescued in humanized mice.
Hofmann I; Geer MJ; Vögtle T; Crispin A; Campagna DR; Barr A; Calicchio ML; Heising S; van Geffen JP; Kuijpers MJE; Heemskerk JWM; Eble JA; Schmitz-Abe K; Obeng EA; Douglas M; Freson K; Pondarré C; Favier R; Jarvis GE; Markianos K; Turro E; Ouwehand WH; Mazharian A; Fleming MD; Senis YA
Blood; 2018 Sep; 132(13):1399-1412. PubMed ID: 29898956
[TBL] [Abstract][Full Text] [Related]
6. Loss-of-function mutations in
Marconi C; Di Buduo CA; LeVine K; Barozzi S; Faleschini M; Bozzi V; Palombo F; McKinstry S; Lassandro G; Giordano P; Noris P; Balduini CL; Savoia A; Balduini A; Pippucci T; Seri M; Katsanis N; Pecci A
Blood; 2019 Mar; 133(12):1346-1357. PubMed ID: 30591527
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopenia.
Bariana TK; Labarque V; Heremans J; Thys C; De Reys M; Greene D; Jenkins B; Grassi L; Seyres D; Burden F; Whitehorn D; Shamardina O; Papadia S; Gomez K; BioResource N; Van Geet C; Koulman A; Ouwehand WH; Ghevaert C; Frontini M; Turro E; Freson K
Haematologica; 2019 May; 104(5):1036-1045. PubMed ID: 30467204
[TBL] [Abstract][Full Text] [Related]
8. A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene.
Manchev VT; Hilpert M; Berrou E; Elaib Z; Aouba A; Boukour S; Souquere S; Pierron G; Rameau P; Andrews R; Lanza F; Bobe R; Vainchenker W; Rosa JP; Bryckaert M; Debili N; Favier R; Raslova H
Blood; 2014 Oct; 124(16):2554-63. PubMed ID: 25061177
[TBL] [Abstract][Full Text] [Related]
9. A missense mutation in the alpha-actinin 1 gene (ACTN1) is the cause of autosomal dominant macrothrombocytopenia in a large French family.
Guéguen P; Rouault K; Chen JM; Raguénès O; Fichou Y; Hardy E; Gobin E; Pan-Petesch B; Kerbiriou M; Trouvé P; Marcorelles P; Abgrall JF; Le Maréchal C; Férec C
PLoS One; 2013; 8(9):e74728. PubMed ID: 24069336
[TBL] [Abstract][Full Text] [Related]
10. New germline GATA1 variant in females with anemia and thrombocytopenia.
Svidnicki MCCM; Filho MAF; Brandão MM; Dos Santos M; de Oliveira Dias R; Tavares RS; Assis-Mendonça GR; Traina F; Saad STO
Blood Cells Mol Dis; 2021 May; 88():102545. PubMed ID: 33611093
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary thrombocytopenia-thrombocytopathy with myelofibrosis (author's transl)].
Delvallez N; Claisse JF; Faille N; Delobel J; Piussan C; Messerschmitt J
Sem Hop; 1980 Jun 18-25; 56(25-28):1154-8. PubMed ID: 6256862
[TBL] [Abstract][Full Text] [Related]
12. Src Acts as an Effector for Ku70-dependent Suppression of Apoptosis through Phosphorylation of Ku70 at Tyr-530.
Morii M; Kubota S; Honda T; Yuki R; Morinaga T; Kuga T; Tomonaga T; Yamaguchi N; Yamaguchi N
J Biol Chem; 2017 Feb; 292(5):1648-1665. PubMed ID: 27998981
[TBL] [Abstract][Full Text] [Related]
13. Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells.
Laird AD; Li G; Moss KG; Blake RA; Broome MA; Cherrington JM; Mendel DB
Mol Cancer Ther; 2003 May; 2(5):461-9. PubMed ID: 12748308
[TBL] [Abstract][Full Text] [Related]
14. [X-linked thrombocytopenia with thalassemia in two families in Sweden. Consider hereditary causes of thrombocytopenia and bone marrow fibrosis].
Danielsson S; Merup M; Olsson L; Palmblad J; Aström M
Lakartidningen; 2012 Aug 22-Sep 4; 109(34-35):1474-7. PubMed ID: 22993897
[No Abstract] [Full Text] [Related]
15. G6b-B regulates an essential step in megakaryocyte maturation.
Becker IC; Nagy Z; Manukjan G; Haffner-Luntzer M; Englert M; Heib T; Vögtle T; Gross C; Bharti R; Dietrich S; Mott K; Heck J; Stegmaier S; Baranowsky A; Schinke T; Schlegel N; Heckel T; Stegner D; Pleines I; Ignatius A; Schulze H; Nieswandt B
Blood Adv; 2022 May; 6(10):3155-3161. PubMed ID: 35134123
[TBL] [Abstract][Full Text] [Related]
16. Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates.
Kuykendall AT; Mo Q; Sallman DA; Ali NA; Chan O; Yun S; Sweet KL; Padron E; Lancet JE; Komrokji RS
Cancer; 2022 Oct; 128(19):3495-3501. PubMed ID: 35942592
[TBL] [Abstract][Full Text] [Related]
17. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
18. Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes.
Elagib KE; Brock A; Clementelli CM; Mosoyan G; Delehanty LL; Sahu RK; Pacheco-Benichou A; Fruit C; Besson T; Morris SW; Eto K; Jobaliya C; French DL; Gadue P; Singh S; Shi X; Qin F; Cornelison R; Li H; Iancu-Rubin C; Goldfarb AN
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 35925681
[TBL] [Abstract][Full Text] [Related]
19. The focal adhesion kinase Pyk2 links Ca2+ signalling to Src family kinase activation and protein tyrosine phosphorylation in thrombin-stimulated platelets.
Canobbio I; Cipolla L; Guidetti GF; Manganaro D; Visconte C; Kim S; Okigaki M; Falasca M; Kunapuli SP; Torti M
Biochem J; 2015 Jul; 469(2):199-210. PubMed ID: 25967238
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocytes and platelets in myeloproliferative disorders.
Briere J; Kiladjian JJ; Peynaud-Debayle E
Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
